Skip to main content

EMBL-DKFZ Chemical Genomics Facility Partners with Tripos on Cheminformatics

NEW YORK, July 20 (GenomeWeb News) - A chemical genomics facility managed by the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) will use informatics software and services from Tripos to help analyze small-molecule screening data, the company said today.

 

The screening facility, based in Heidelberg, Germany, was launched in March and employs six full-time researchers.

 

Under the terms of the agreement, Tripos Discovery Research, Tripos' UK-based chemistry division, will provide the facility with a chemistry database and other chemistry processes to assist with hit finding, hit follow-up, and chemical optimization of candidate molecules.

 

Financial terms of the collaboration were not disclosed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.